USPSTF Recommends Against Routine Screening for Carotid Artery Stenosis
Risks Outweigh Benefits in General Population
By News Staff
2/5/2008
The reliability of the most feasible screening test for severe CAS -- carotid duplex ultrasonography -- has not been established; such testing often yields false-positive results. Positive results are most often confirmed by digital subtraction angiography, which itself can cause strokes in certain patients. Other confirmatory tests, such as magnetic resonance angiography, may be inaccurate. Thus, some individuals with false-positive results will receive unnecessary invasive carotid endarterectomy surgery.
In addition, despite good evidence showing that carotid endarterectomy among selected high-risk clinical trial participants with asymptomatic severe CAS can reduce the five-year absolute incidence of all strokes or perioperative deaths by about 5 percent, the projected benefits among the general primary care population were judged to be "no greater than small," said the task force.
Risk factors for CAS include older age, male gender, hypertension, smoking, hypercholesterolemia and heart disease. Instead of screening for CAS in the general adult population, the USPSTF recommends that physicians screen their patients for hypertension, hyperlipidemia and smoking. For patients who are at increased risk of heart disease, physicians should discuss aspirin chemoprevention.
It's worth noting that this USPSTF recommendation applies only to adult patients who have no neurological signs or symptoms, including a history of transient ischemic attacks, or TIAs, or stroke. Eligible patients who have a carotid TIA should be evaluated immediately for consideration of carotid endarterectomy.
FDA Panel Recommends Acetaminophen Restrictions
ACIP Gives Thumbs-up to New Antiviral Recs
CDC Reinstates Hib Booster for 12- to 15-month-olds
Committee Recommends A1c Testing for Diabetes Diagnosis
CDC Urges Health Workers to Avoid H1N1 Infection
WHO Declares Pandemic, But Little Else Changes
AAFP Posts New Pregnancy-related Clinical Services Recommendations
Thyroid Drug Linked to Liver Injury, FDA Warns
IOM Updates Guidelines for Weight Gain in Pregnancy
Manufacturers to Begin Work on H1N1 Vaccine
Role of FPs in Prenatal Care Declining Even in Rural Areas
CDC Considering Early Start to Flu Vaccinations
CDC Urges Docs Not to Hoard Hep B Vaccine Doses
H1N1 Flu: CDC Updates Antiviral Guidance
FDA Requiring Label Changes for Botox Products








